Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Filings indexed 331 across all filing types
Latest filing 2021-06-21 M&A Activity
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Uttalande från Elos Medtechs styrelse med anledning av TA Associates offentliga uppköpserbjudande
M&A Activity Classification · 98% confidence The document is a formal statement from the Board of Directors of Elos Medtech AB regarding a public takeover offer made by TA Associates. The text explicitly mentions the offer terms, the board's unanimous recommendation to accept the offer, and includes a 'fairness opinion' from Grant Thornton. This structure—a board statement responding to a takeover bid, often mandated by takeover regulations (like the Nasdaq Stockholm takeover rules mentioned), and including an independent financial assessment—is characteristic of documents related to M&A activity, specifically a takeover bid response. The relevant filing category is 'M&A Activity' (TAR). It is not a general regulatory filing (RNS) because it is highly specific to a takeover, nor is it a proxy statement (PSI) or a general earnings release (ER).
2021-06-21 Swedish
Statement by the board of directors of Elos Medtech regarding the public offer from TA Associates
M&A Activity Classification · 98% confidence The document is a formal statement by the board of directors of Elos Medtech regarding a public offer (takeover bid) from TA Associates. It explicitly mentions the 'Nasdaq Stockholm Takeover Rules' and includes a 'fairness opinion' from Grant Thornton regarding the offer price. This type of document, which details a takeover proposal, the board's recommendation, and supporting expert opinions, strongly aligns with documents related to Mergers & Acquisitions (M&A) activity or takeover bids. The definition for M&A Activity (Code: TAR) is 'Announcements and documents related to merger proposals or takeover bids.' Although it is a board statement, its core subject is the takeover bid, making TAR the most appropriate classification over general Regulatory Filings (RNS) or Director's Dealing (DIRS). The document length is substantial (over 12,000 characters), confirming it is the primary document, not just an announcement of a report.
2021-06-21 English
Comment from Elos Medtech’s Board of Directors regarding the public offer from TA Associates
M&A Activity Classification · 99% confidence The document is a formal comment from the Board of Directors of Elos Medtech regarding a public offer (takeover bid) made by TA Associates. It discusses the offer price, the expected timeline for the offer document, and the board's intention to evaluate the offer and publish its opinion. This content directly relates to a merger or takeover proposal. Reviewing the definitions, the category 'M&A Activity (Code: TAR)' is described as 'Announcements and documents related to merger proposals or takeover bids.' This perfectly matches the subject matter of the document, which is a response to a public takeover offer.
2021-06-11 English
Kommentar från Elos Medtechs styrelse angående uppköpserbjudandet från TA Associates
M&A Activity Classification · 99% confidence The document text is a formal announcement from the Board of Directors of Elos Medtech regarding a public takeover bid (uppköpserbjudande) made by TA Associates. Key phrases include 'offentligt uppköpserbjudande' (public takeover offer), 'Erbjudandet' (The Offer), and details about the offer price, timeline, and advisors (Carnegie, Vinge, Grant Thornton). This content directly relates to a merger or takeover proposal. Based on the definitions, the category 'M&A Activity (Code: TAR)' is the most appropriate fit, as it covers 'Announcements and documents related to merger proposals or takeover bids.' The document is short and is an announcement, but its specific subject matter (takeover bid) overrides the general 'RPA' or 'RNS' classification.
2021-06-11 Swedish
Uttalande från Elos Medtech om senaste tidens kursutveckling: diskussioner förs om ett eventuellt uppköpserbjudande
M&A Activity Classification · 99% confidence The document text is a formal announcement from Elos Medtech AB regarding discussions with a party concerning a potential public takeover bid ('eventuellt offentligt uppköpserbjudande'). It mentions a non-binding indicative price of 215 SEK per share. This content directly relates to merger proposals or takeover bids. Based on the definitions, this aligns perfectly with the 'M&A Activity' category, which has the code TAR.
2021-06-01 Swedish
Elos Medtech statement regarding recent share price development: talks regarding a possible takeover bid are ongoing
M&A Activity Classification · 99% confidence The document explicitly discusses ongoing discussions regarding a 'possible takeover bid' and mentions a specific offer price (SEK 215 per share). This content directly relates to merger or acquisition activity. According to the definitions, 'M&A Activity (Code: TAR)' covers 'Announcements and documents related to merger proposals or takeover bids.' The document is short and serves as an announcement regarding this activity, making TAR the most appropriate classification.
2021-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.